|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
Epithelial cell
|
Cell type |
|
|
Bone marrow
|
Organism part |
|
|
None
|
Compound treatment |
|
|
Peripheral blood
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
Glioblastoma
|
Disease state |
|
|
Fibroblast
|
Cell type |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Lung
|
Organism part |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
ERbeta transfected
|
Genotype |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
White blood cells
|
Organism part |
|
|
Tumor
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Bladder carcinoma
|
Disease state |
|
|
Caudate nucleus
|
Organism part |
|
|
Keratinocyte
|
Cell type |
|
|
Grade IV
|
Tumor grading |
|
|
Endothelial cell
|
Cell type |
|
|
ERalpha transfected
|
Genotype |
|
|
CodeLink Labeling
|
Protocol type |
|
|
HTERT/HPVE6/HPVE7/SV40t/hRas t...
|
Gene modification |
|
|
Primary fibroblast
|
Cell type |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
Enzo Labeling
|
Protocol type |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
TaN0M0
|
Disease staging |
|
|
G2
|
Tumor grading |
|
|
Skin
|
Organism part |
|
|
Primary CD34- mesenchymal stem...
|
Cell type |
|
|
None
|
Gene modification |
|
|
Skin substitute
|
Cell type |
|
|
Methotrexate
|
Compound treatment |
|
|
Uninfected
|
Infection |
|
|
N/a
|
Test result |
|
|
G3
|
Tumor grading |
|
|
Breast carcinoma
|
Disease state |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
GLI72
|
Cell line |
|
|
CD3high CD4+ CD8-
|
Phenotype |
|
|
Single positive thymocyte
|
Cell type |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
Whole blood
|
Organism part |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
A549
|
Cell line |
|
|
Chondrocyte
|
Cell type |
|
|
Astrocyte
|
Cell type |
|
|
HeLa
|
Cell line |
|
|
Not applicable
|
Histology |
|
|
Primary blood vessel endotheli...
|
Cell type |
|
|
Pancreatic cancer
|
Disease state |
|
|
Pan paniscus
|
Organism |
|
|
4OH-tamoxifen
|
Compound treatment |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Lymphoid tissue
|
Organism part |
|
|
Lymph node
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Primary smooth muscle cell
|
Cell type |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
Seminiferous tubule
|
Organism part |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
267B1
|
Cell line |
|
|
267B1_Ki-ras
|
Cell line |
|
|
Immediately after exercise
|
Clinical info |
|
|
Cerebellum
|
Organism part |
|
|
GLI56
|
Cell line |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Adipocyte
|
Cell type |
|
|
Primary lymphatic endothelial ...
|
Cell type |
|
|
CD3- CD4+ CD8-
|
Phenotype |
|
|
Intrathymic T progenitor cell
|
Cell type |
|
|
Primary
|
Disease staging |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
Epilepsy
|
Disease state |
|
|
Spermatocyte
|
Cell type |
|
|
Sporadic basal-like breast can...
|
Disease state |
|
|
Skeletal muscle
|
Organism part |
|
|
Head and neck squamous cell ca...
|
Disease state |
|
|
Homo sapiens
|
Organism |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Control
|
Disease state |
|
|
Benign nevi
|
Disease state |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
BT474
|
Cell line |
|
|
Carboplatin resistant
|
Test result |
|
|
Carboplatin sensitive
|
Test result |
|
|
Cystic change
|
Histology |
|
|
Normal
|
Clinical history |
|
|
ERalpha/beta transfected
|
Genotype |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
U266
|
Cell line |
|
|
Respiratory syncytial virus
|
Infection |
|
|
Cartilage
|
Organism part |
|
|
Pseudomonas aeruginosa
|
Infection |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Obesity
|
Disease state |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Beas2B
|
Cell line |
|
|
Age-related macular degenerati...
|
Disease state |
|
|
HTERT transfection
|
Gene modification |
|
|
Arsenic oxide
|
Compound treatment |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
GLI60
|
Cell line |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
Pan troglodytes
|
Organism |
|
|
Intraepithelium
|
Organism part |
|
|
Pancreatic ductal adenocarcino...
|
Disease state |
|
|
Basal cell
|
Cell type |
|
|
Duodenum
|
Organism part |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Testis
|
Organism part |
|
|
Central memory 1 CD4 T cell
|
Target cell type |
|
|
CFT-2
|
Cell line |
|
|
NT-1
|
Cell line |
|
|
Duchenne muscular dystrophy
|
Disease state |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Primary gastric tumor
|
Organism part |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Nocodazole
|
Compound treatment |
|
|
Hydroxyurea
|
Compound treatment |
|
|
Senescence bypassed
|
Phenotype |
|
|
KSHV infection
|
Disease state |
|
|
60 min after exercise
|
Clinical info |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
Trigeminal ganglion
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
Adipose tissue
|
Organism part |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Extra-adrenal sympathetic para...
|
Disease state |
|
|
Adrenal gland pheochromocytoma
|
Disease state |
|
|
Male
|
Sex |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Congestive cardiomyopathy
|
Disease state |
|
|
Atrioventricular node
|
Organism part |
|
|
YCC16
|
Cell line |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
AIDS-KS, HIV+, nodular (late) ...
|
Disease state |
|
|
ITV
|
Cell line |
|
|
Actinomycin D
|
Compound treatment |
|
|
HTERT/HPVE6 transfection
|
Gene modification |
|
|
Macaca mulatta
|
Organism |
|
|
Vasectomized
|
Clinical history |
|
|
Low grade glioblastoma
|
Disease state |
|
|
Tumor cell
|
Cell type |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Stage I
|
Disease staging |
|
|
Phenol
|
Compound treatment |
|
|
High grade glioblastoma
|
Disease state |
|
|
DMSO
|
Vehicle |
|
|
Germ cell
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Control
|
Compound treatment |
|
|
Placebo
|
Compound treatment |
|
|
U937
|
Cell line |
|
|
Liver
|
Organism part |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Thymus
|
Organism part |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Spleen
|
Organism part |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Umbilical cord
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Heart
|
Organism part |
|
|
T4aN2M0
|
Disease staging |
|
|
Control
|
Phenotype |
|
|
T1aN0M0
|
Disease staging |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
PDGF-A dominant-negative
|
Genotype |
|
|
Leydig cell
|
Cell type |
|